Dr. Elizabeth M. Traverse, an epidemiologist and molecular biologist, specializes in viral immunopathology and the public health impact of emerging infectious diseases. Her work bridges molecular virology and epidemiological modeling, with a focus on arboviruses, cardiotropic viruses, and neglected tropical diseases. Using techniques such as qPCR, ELISA, and next-generation sequencing, she has investigated viral-induced cardiomyopathy and immune responses in human stem cell-derived models. At the Cleveland Clinic, her research contributed to antiviral drug evaluation and mechanistic insights into host-pathogen interactions. Dr. Traverse integrates statistical modeling in R and Python with experimental data to inform risk mitigation strategies and guide public health decision-making. Her recent publications explore organ-specific manifestations of Chikungunya virus and viral outcomes in vulnerable populations. Passionate about translating science into practice, she has advised cross-disciplinary teams and taught public health immunology to over 1,200 students. Her work supports global health efforts to strengthen diagnostics, surveillance, and epidemic preparedness.